yrbG Antibody

Shipped with Ice Packs
In Stock

Description

Scope of Antibody Research Covered in Sources

The provided materials focus on well-characterized antibodies in virology (e.g., HIV bNAbs like PGDM1400 , influenza RBS-directed antibodies ), structural biology (e.g., immunoglobulin domains ), and therapeutic applications (e.g., recombinant antibodies ). Initiatives like YCharOS and databases such as AbDb emphasize antibody validation and standardization but do not reference "yrbG."

Analysis of Potential Terminology

  • "yrbG" does not correspond to standard antibody nomenclature (e.g., CD20, HER2) or gene/protein identifiers (e.g., IL-6, TNF-α).

  • It is not listed in antibody repositories (AbDb ), therapeutic catalogs , or structural databases (PDB).

  • No matches were found in influenza, HIV, or autoimmune research contexts .

Possible Explanations for Missing Data

  • Typographical Error: "yrbG" may be a misspelling (e.g., "yrbD" in Bacillus subtilis or "yrbG" in bacterial operons, though unrelated to antibodies).

  • Proprietary or Obscure Target: The term could refer to an unpublished, proprietary antibody or a highly specialized research reagent not yet cataloged.

  • Species-Specific Antigen: If "yrbG" originates from a non-human model organism (e.g., plant or bacterial systems), it may lack cross-disciplinary documentation.

Recommendations for Further Investigation

To resolve this gap, consider:

  • Re-examining Spelling: Verify the term against standardized databases like UniProt, NCBI Gene, or IEDB.

  • Expanding Search Parameters: Query specialized repositories (e.g., CiteAb, Antibody Registry) or preprint servers (e.g., bioRxiv).

  • Consulting Primary Literature: Investigate niche journals focused on microbial genomics or synthetic biology, where "yrbG" may appear in non-antibody contexts.

Related Antibody Research Context

While "yrbG Antibody" remains unidentified, the search results highlight critical advancements in antibody science:

FeatureExamples from LiteratureRelevance
Recombinant AntibodiesHIV triple therapy (PGT121 + PGDM1400 + VRC07-523LS) High specificity, modular design principles
Structural ValidationYCharOS antibody characterization Rigorous validation workflows to ensure reproducibility
Therapeutic ApplicationsAntibody-drug conjugates Engineered for targeted delivery in cancer and autoimmune diseases

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
yrbG antibody; b3196 antibody; JW3163 antibody; Inner membrane protein YrbG antibody
Target Names
yrbG
Uniprot No.

Target Background

Database Links
Protein Families
Ca(2+):cation antiporter (CaCA) (TC 2.A.19) family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the yrbG protein and why is it significant for bacterial physiology research?

The yrbG protein (325 amino acids) functions as a putative Na⁺/Ca²⁺ exchanger in the Escherichia coli inner membrane, belonging to a family of ion transporters with homology to eukaryotic exchangers . Its significance stems from its unique structural organization, featuring two homologous halves with five transmembrane segments each, but with opposite membrane orientations . This unusual topology provides an excellent model for studying membrane protein evolution and ion transport mechanisms. Additionally, yrbG appears functionally connected to proteins involved in lipopolysaccharide biogenesis, suggesting broader roles in bacterial envelope development .

Current research indicates yrbG functions in calcium and sodium ion homeostasis, which has implications for bacterial survival under various environmental stresses. The protein's evolutionary relationship to eukaryotic ion exchangers makes it valuable for comparative studies of ion transport mechanisms across domains of life.

What are the critical considerations for generating specific antibodies against the yrbG protein?

Generating specific antibodies against yrbG requires careful attention to several factors due to its membrane-embedded nature:

  • Topology-informed epitope selection: Since yrbG has multiple transmembrane domains, researchers should target hydrophilic regions predicted to be exposed either to the cytoplasm or periplasm. The protein's opposing orientation of its two halves means different epitope selection strategies may be needed depending on which region is of interest .

  • Sequence uniqueness assessment: Selected epitopes must be unique to yrbG to prevent cross-reactivity with other bacterial membrane transporters. This requires comprehensive sequence analysis against the E. coli proteome.

  • Expression system optimization: For recombinant protein production, membrane proteins like yrbG often require specialized expression systems with careful detergent selection for solubilization without destroying native epitopes.

  • Validation against genetic controls: Essential validation should include testing against wild-type E. coli strains versus yrbG knockout mutants to confirm specificity.

When developing polyclonal antibodies, immunizing with multiple epitopes can increase the chances of obtaining antibodies that recognize the native protein in various applications.

How do researchers navigate the challenges of antibody validation specific to membrane proteins like yrbG?

Validating antibodies against membrane proteins like yrbG presents unique challenges that require specialized approaches:

  • Multi-platform validation strategy: Confirmation across multiple techniques is essential:

    • Western blotting with membrane-enriched fractions

    • Immunoprecipitation with appropriate detergent selection

    • Immunofluorescence with proper membrane permeabilization protocols

    • Flow cytometry with fixation optimization

  • Genetic validation controls: The most definitive controls include:

    • Wild-type E. coli (positive control)

    • ΔyrbG deletion mutants (negative control)

    • yrbG overexpression strains (enhanced signal control)

  • Epitope accessibility assessment: Different experimental conditions affect epitope exposure:

    ConditionEpitope AccessibilityApplications
    NativeConformational epitopes preservedIP, IF, Flow cytometry
    DenaturedLinear epitopes exposedWestern blot
    Partially denaturedMixed accessibilityELISA
  • Cross-reactivity testing: Antibodies should be tested against related proteins, particularly other ion transporters, to ensure specificity.

Due to the complex nature of membrane proteins, researchers should expect to optimize detergent conditions extensively and may need different antibody preparations for different applications .

What are the optimal sample preparation methods for detecting yrbG in Western blot applications?

Optimizing sample preparation is crucial for successful Western blot detection of membrane proteins like yrbG:

  • Effective membrane protein extraction:

    • Use specialized membrane protein extraction buffers containing mild detergents (0.5-1% DDM or CHAPS)

    • Avoid harsh detergents like SDS during initial extraction as they may denature conformational epitopes

    • Consider using membrane fractionation techniques to enrich for inner membrane proteins

  • Sample denaturation considerations:

    • Avoid extended boiling which can cause membrane protein aggregation

    • Use moderate heating (65-70°C for 5-10 minutes) in sample buffer

    • Include reducing agents (DTT or β-mercaptoethanol) to disrupt disulfide bonds

  • Electrophoresis optimization:

    • Select appropriate gel percentage (10-12% for yrbG's 35-38 kDa size range)

    • Consider gradient gels for better resolution

    • Use specialized transfer conditions for membrane proteins (longer transfer times or specialized buffers)

  • Detection optimization:

    • Primary antibody concentrations typically range from 1:1000-1:5000

    • Extended incubation times (overnight at 4°C) often improve signal quality

    • Consider enhanced chemiluminescence detection for maximum sensitivity

When analyzing results, researchers should be aware that membrane proteins often migrate at apparent molecular weights different from their calculated values due to differential SDS binding to hydrophobic regions.

How can researchers distinguish between specific and non-specific signals when using yrbG antibodies?

Distinguishing specific from non-specific signals requires implementation of rigorous controls and optimization strategies:

  • Essential controls for establishing specificity:

    • Genetic controls: Compare wild-type to ΔyrbG strains

    • Peptide competition: Pre-incubation of antibody with immunizing peptide should abolish specific signals

    • Secondary-only controls: Detect non-specific binding of secondary antibodies

    • Pre-immune serum comparison: For polyclonal antibodies

  • Signal validation approaches:

    • Multiple antibody approach: Use antibodies targeting different epitopes of yrbG

    • Recombinant protein positive control: Include purified yrbG protein

    • Tag-based validation: Compare with detection of epitope-tagged yrbG

  • Non-specific binding reduction strategies:

    StrategyImplementationBenefit
    Blocking optimizationTest different blocking agents (milk, BSA, casein)Reduces background
    Detergent adjustmentIncrease Tween-20 concentration in wash buffersRemoves weak interactions
    Antibody titrationTest multiple dilutions to find optimal signal-to-noiseBalances sensitivity and specificity
    Cross-adsorptionPre-incubate antibody with E. coli lysate lacking yrbGRemoves cross-reactive antibodies
  • Quantitative assessment:

    • Calculate signal-to-noise ratios across different conditions

    • Use digital image analysis to objectively measure relative intensities

    • Compare signal patterns across multiple detection methods

Researchers should approach unexpected signals with particular skepticism, especially when they appear at molecular weights significantly different from yrbG's predicted size.

What experimental strategies allow for effective co-localization studies of yrbG with other membrane proteins?

Performing co-localization studies with yrbG requires careful attention to preserve native spatial relationships between membrane proteins:

Special attention should be paid to E. coli's small size, which challenges the resolution limits of standard fluorescence microscopy, making super-resolution techniques particularly valuable for definitive co-localization studies.

How can antibodies be used to investigate the ion transport function of yrbG?

Antibodies provide powerful tools for studying yrbG's ion transport function through several sophisticated approaches:

  • Functional inhibition studies:

    • Apply antibodies targeting different domains to identify regions critical for transport

    • Measure Na⁺/Ca²⁺ flux in membrane vesicles with and without antibody pretreatment

    • Use Fab fragments for better access to membrane-proximal epitopes

  • Conformational state detection:

    • Develop conformation-specific antibodies that recognize different states of the transport cycle

    • Use antibody accessibility assays to map conformational changes during transport

    • Compare epitope exposure in the presence vs. absence of transport substrates or inhibitors

  • Complex assembly analysis:

    • Investigate interactions with other membrane proteins involved in ion homeostasis

    • Assess stoichiometry changes under different ionic conditions

    • Map the relationship between yrbG and lipopolysaccharide biogenesis machinery

  • In vivo transport dynamics:

    ApproachMethodologyInformation Gained
    Single-molecule trackingConjugate quantum dots to Fab fragmentsReal-time movement and clustering
    FRET sensorsCombine antibody fragments with fluorescent ion indicatorsLocal ion concentration changes
    Proximity labelingAntibody-directed enzyme-mediated labelingIdentification of transport-associated proteins
  • Structure-function analysis:

    • Use epitope mapping to correlate functional domains with structural features

    • Compare antibody binding profiles between wild-type and transport-deficient mutants

    • Facilitate structural studies by using antibodies to stabilize specific conformations

These approaches collectively can reveal mechanistic insights into how yrbG's unique topology with oppositely oriented halves contributes to its ion transport function .

What strategies can researchers use to study protein-protein interactions involving yrbG?

Investigating protein-protein interactions involving yrbG requires specialized approaches due to its membrane localization:

  • Optimized co-immunoprecipitation protocols:

    • Detergent selection is critical: mild detergents (DDM, CHAPS) preserve interactions

    • Crosslinking prior to extraction can stabilize transient interactions

    • Use membrane-compatible buffer systems with physiological ion concentrations

  • Proximity-based interaction methods:

    • Proximity ligation assay (PLA) with anti-yrbG and putative partner antibodies

    • FRET/BRET using antibody fragments or nanobodies

    • Split reporter systems (luciferase, GFP) combined with antibody validation

  • Peptide-based interaction mapping:

    • Use antibodies to validate interactions identified in peptide array screening

    • Competition assays with domain-specific antibodies to map interaction regions

    • Antibody epitope mapping to identify binding interfaces

  • Interaction network analysis:

    MethodApplicationAdvantage
    BioID/TurboIDIn vivo proximity labelingIdentifies weak/transient interactions
    Chemical crosslinkingCovalent capture of interactorsPreserves membrane complex architecture
    Co-evolution analysisComputational prediction validated by antibodiesIdentifies evolutionarily conserved interactions
  • Functional validation approaches:

    • Antibody inhibition of predicted interactions

    • Mutational analysis of interaction interfaces identified by antibody mapping

    • Reconstitution assays with purified components and antibody detection

Research has indicated potential functional connections between yrbG and proteins involved in lipopolysaccharide biogenesis, suggesting important roles in bacterial envelope development that can be further elucidated using these methods .

How can researchers use antibodies to investigate the evolutionary relationships between yrbG and related transporters?

Antibodies offer unique tools for exploring evolutionary relationships between yrbG and related transporters across bacterial species:

  • Cross-reactivity profiling:

    • Test anti-yrbG antibodies against homologs from diverse bacterial species

    • Map conservation of epitopes across evolutionary distance

    • Correlate antibody binding with functional conservation

  • Epitope conservation analysis:

    • Generate antibodies against highly conserved vs. divergent regions

    • Compare accessibility of conserved epitopes across species

    • Use antibody binding profiles to complement sequence-based phylogenetic analyses

  • Structure-function conservation assessment:

    • Test whether antibodies against functional domains cross-react with homologs

    • Compare antibody inhibition of transport activity across species

    • Evaluate conservation of conformational epitopes between distant homologs

  • Evolutionary adaptation detection:

    ApproachMethodologyInsight Gained
    Species-specific antibodiesTarget divergent regionsIdentify species-specific adaptations
    Function-blocking antibodiesTransport inhibition across speciesConservation of functional mechanisms
    Conformational epitope mappingCompare across taxaStructural conservation despite sequence divergence
  • Horizontal gene transfer investigation:

    • Use antibodies to trace unexpected conservation patterns

    • Identify mosaic proteins with epitopes from different evolutionary origins

    • Detect strain-specific variations that suggest recent transfer events

The unique topology of yrbG, with its two halves having opposite membrane orientations, presents an excellent model for studying the evolution of membrane protein structure . Antibody-based approaches can reveal whether this unusual arrangement is conserved across species and provide insights into the evolutionary history of ion transport mechanisms.

How should researchers address contradictory results between different antibody-based detection methods for yrbG?

Contradictory results between different antibody-based detection methods require systematic troubleshooting and reconciliation:

  • Methodological differences assessment:

    • Epitope accessibility varies dramatically between methods:

      • Western blot: Denatured proteins expose linear epitopes

      • Immunofluorescence: Fixation affects epitope availability

      • Flow cytometry: Surface exposure requirements differ

      • Immunoprecipitation: Native conformation preservation varies

  • Antibody characteristics analysis:

    • Verify antibody specificity in each method using genetic controls

    • Consider that different antibody clones may recognize distinct epitopes

    • Evaluate affinity and avidity requirements for each method

  • Resolution framework:

    Contradiction TypeInvestigation ApproachResolution Strategy
    WB positive, IF negativeTest multiple fixation/permeabilization methodsOptimize for epitope accessibility
    IF positive, WB negativeTest native vs. reducing conditions in WBIdentify conformational dependencies
    Inconsistent molecular weightCompare membrane preparation methodsAddress post-translational modifications
    Method-specific backgroundInclude absorption controlsDevelop method-specific blocking strategies
  • Orthogonal validation approaches:

    • Implement non-antibody detection methods (mass spectrometry)

    • Use epitope tagging with detection via anti-tag antibodies

    • Apply CRISPR-based endogenous tagging for validation

  • Biological variability considerations:

    • Test for expression differences under various growth conditions

    • Assess potential post-translational modifications affecting detection

    • Consider expression timing during bacterial growth phases

When reporting findings, researchers should explicitly address methodological differences and provide a unifying model explaining apparent contradictions rather than selectively reporting supportive results .

What statistical approaches are most appropriate for analyzing quantitative data from yrbG antibody experiments?

Quantitative analysis of yrbG antibody data requires appropriate statistical approaches tailored to the specific experimental design:

  • Expression level quantification:

    • Normalization strategy selection:

      • Housekeeping membrane proteins for Western blot (not cytosolic proteins)

      • Total protein staining methods (Ponceau, REVERT)

      • Cell number normalization for flow cytometry

  • Replicate design and analysis:

    • Technical replicates: Multiple measurements from same biological sample

    • Biological replicates: Independent bacterial cultures

    • Nested designs: Account for both sources of variation

  • Statistical test selection:

    Data TypeAppropriate TestsConsiderations
    Paired measurementsPaired t-test, Wilcoxon signed-rankBefore/after treatments
    Multiple conditionsANOVA with post-hoc testsCorrection for multiple comparisons
    Non-normal dataNon-parametric testsCommon with antibody-based quantification
    Correlation analysisPearson/Spearman correlationMethod comparison or co-expression
  • Power analysis considerations:

    • Calculate required sample sizes based on expected effect sizes

    • Account for higher variability in membrane protein detection

    • Consider batch effects with antibody lots

  • Advanced analysis approaches:

    • Linear mixed models to handle complex experimental designs

    • Bayesian analysis for small sample sizes

    • Machine learning for pattern recognition in complex datasets

Researchers should report not only statistical significance but also effect sizes and confidence intervals. For membrane proteins like yrbG, special attention should be paid to technical variability introduced by sample preparation methods, which often exceeds biological variability .

How can researchers effectively validate the specificity of yrbG antibodies across different experimental contexts?

Comprehensive validation of yrbG antibody specificity across experimental contexts requires a multi-faceted approach:

  • Genetic validation controls:

    • Wild-type vs. ΔyrbG knockout comparison in each experimental system

    • Complementation testing (knockout with plasmid-expressed yrbG)

    • Overexpression systems for positive control

  • Cross-platform validation strategy:

    • Start with Western blot validation using clear genetic controls

    • Extend to immunofluorescence with matched fixation/permeabilization

    • Validate in co-immunoprecipitation with appropriate detergent conditions

    • Confirm with flow cytometry using optimized preparation protocols

  • Epitope verification approaches:

    ApproachMethodologyInformation Gained
    Peptide competitionPre-incubation with immunizing peptideConfirms epitope specificity
    Epitope mappingOverlapping peptide arraysDefines exact recognition sequence
    MutagenesisTargeted amino acid substitutionsIdentifies critical binding residues
  • Cross-reactivity assessment:

    • Test against closely related bacterial ion transporters

    • Examine detection in heterologous expression systems

    • Evaluate species cross-reactivity if working across bacterial species

  • Method-specific validation:

    • For immunofluorescence: Co-localization with known membrane markers

    • For Western blot: Migration pattern analysis

    • For IP: Mass spectrometry confirmation of pulled-down proteins

    • For ELISA: Standard curve analysis with recombinant protein

The most robust validation combines multiple approaches and explicitly tests the antibody in each experimental context where it will be used, rather than assuming transferability of specificity between methods .

How might antibodies facilitate structural studies of the yrbG transporter?

Antibodies offer several strategic advantages for structural studies of challenging membrane proteins like yrbG:

  • Crystallography applications:

    • Fab fragment co-crystallization to provide crystal contacts

    • Conformational stabilization by locking the protein in specific states

    • Reduction of flexible regions that hinder crystallization

  • Cryo-electron microscopy enhancement:

    • Increased particle size for improved alignment and classification

    • Antibody labels for orientation determination

    • Visualization of conformational heterogeneity through differential antibody binding

  • Structural epitope mapping approaches:

    MethodImplementationStructural Information
    Hydrogen-deuterium exchangeCompare exchange patterns with/without antibodyBinding interface identification
    Crosslinking mass spectrometryIdentify crosslinks altered by antibody bindingConformational changes upon binding
    EPR spectroscopySite-directed spin labeling with antibody bindingDistance measurements and dynamics
  • Functional structural analysis:

    • Antibodies targeting specific domains to correlate structure with function

    • Comparison of apo- versus substrate-bound structures using conformation-specific antibodies

    • Investigation of how the unique opposing orientation of yrbG's two halves contributes to transport mechanism

  • Emerging methodological combinations:

    • Nanobody-based structural analysis for minimal perturbation

    • Lipid nanodisc reconstitution with antibody stabilization

    • Single-particle tracking with conformation-specific antibodies

These approaches can provide crucial insights into how yrbG's unusual topology with opposite membrane orientations of its homologous halves contributes to its ion transport mechanism, potentially revealing new paradigms in membrane protein evolution and function .

What potential exists for developing therapeutic applications based on yrbG antibody research?

While primarily a research tool, yrbG antibody studies could contribute to therapeutic applications through several pathways:

  • Antimicrobial strategy development:

    • Target validation: Determine if yrbG inhibition affects bacterial viability

    • Epitope identification: Map functionally critical regions as drug targets

    • Screening platform: Use antibody competition assays to discover small molecule inhibitors

  • Diagnostic applications:

    • Species-specific detection: Develop antibodies distinguishing pathogenic E. coli variants

    • Bacterial load quantification: Create sensitive immunoassays

    • Antibiotic response monitoring: Track membrane protein remodeling during treatment

  • Drug discovery facilitation:

    ApplicationMethodologyPotential Impact
    Structure-based drug designAntibody-facilitated structural studiesRational inhibitor development
    Transport assay developmentAntibody-based sensors of conformational changesHigh-throughput screening platforms
    In vivo imagingLabeled antibody fragments for trackingInfection progression monitoring
  • Resistance mechanism understanding:

    • Study ion transport changes in antibiotic-resistant strains

    • Investigate membrane adaptation mechanisms

    • Explore connections between ion homeostasis and antibiotic efficacy

  • Translational research directions:

    • Examine yrbG homologs in pathogenic bacteria

    • Investigate cross-species conservation for broad-spectrum approaches

    • Explore connections between ion transport inhibition and virulence

As a putative Na⁺/Ca²⁺ exchanger with connections to lipopolysaccharide biogenesis pathways, yrbG represents an interesting potential target at the intersection of ion homeostasis and cell envelope integrity, both critical for bacterial survival .

How can machine learning approaches enhance antibody-based analysis of yrbG expression patterns?

Machine learning offers powerful tools for enhancing antibody-based analysis of yrbG expression:

  • Image analysis automation:

    • Automated cell segmentation in immunofluorescence images

    • Quantitative pattern recognition of subcellular localization

    • Multi-channel co-localization analysis with statistical validation

  • Expression pattern classification:

    • Supervised learning to identify growth condition-specific expression patterns

    • Anomaly detection for identifying unusual expression phenotypes

    • Correlation of expression patterns with physiological states

  • Multi-omics data integration:

    ML ApproachImplementationResearch Benefit
    Dimensionality reductionPCA/t-SNE of expression data across conditionsIdentify key regulatory patterns
    Clustering algorithmsGroup similar expression profilesDiscover co-regulated systems
    Neural networksPredict expression from environmental conditionsModel regulatory networks
  • Experimental design optimization:

    • Active learning for optimal sampling of experimental conditions

    • Transfer learning to apply knowledge between related membrane proteins

    • Reinforcement learning for automated microscopy acquisition

  • Antibody-specific applications:

    • Epitope prediction improvement for next-generation antibody development

    • Cross-reactivity prediction across bacterial species

    • Automated quality control of antibody specificity across applications

These computational approaches can transform antibody-based detection from qualitative observation to quantitative, systems-level analysis, potentially revealing how yrbG expression integrates with broader cellular processes such as lipopolysaccharide biogenesis and stress response pathways .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.